نتایج جستجو برای: angiopoietin

تعداد نتایج: 3153  

Journal: :Critical Care 2008
Alexander Lukasz Julian Hellpap Rüdiger Horn Jan T Kielstein Sascha David Hermann Haller Philipp Kümpers

INTRODUCTION In critically ill patients, the massive release of angiopoietin-2 (Ang-2) from endothelial Weibel-Palade bodies interferes with constitutive angiopoietin-1 (Ang-1)/Tie2 signaling in endothelial cells, thus leading to vascular barrier breakdown followed by leukocyte transmigration and capillary leakage. The use of circulating Ang-1 and Ang-2 as novel biomarkers of endothelial integr...

Journal: :World journal of emergency medicine 2011
Hai-Bin Weng Sen Li

BACKGROUND This study was undertaken to investigate the early changes of plasma levels of angiopoietin-2 (Ang-2) in patients with multiple trauma and the relations of plasma Ang-2, endothelial injury, and prognosis. METHODS This study comprised 59 patients with multiple trauma who had been treated at the emergency department of Liao Cheng People's Hospital from January 2008 to January 2010. A...

2014
Kuk-Young Moon PuReun-HaNeul Lee Sung-Woo Park Choon-Sik Park An-Soo Jang

BACKGROUND Angiopoietin-1 (Ang-1) is an essential mediator of angiogenesis that establishes vascular integrity, and angiopoietin-2 (Ang-2) acts as its natural inhibitor. We considered that angiopoietin might be important in bronchial asthma. METHODS In total, 35 patients with asthma and 20 healthy subjects were studied. RESULTS The serum Ang-1 levels were significantly elevated in patients ...

Journal: :Cancer research 2013
Damien Gerald Sudhakar Chintharlapalli Hellmut G Augustin Laura E Benjamin

Anti-VEGF pathway therapies primarily target immature blood vessels in tumors. However, emerging approaches to combine with targeted therapies impacting the later stages of remodeling and vessel maturation are expected to improve clinical efficacy by expanding the target vessel population. The angiopoietin/Tie ligand/receptor system is a prototypic regulator of vessel remodeling and maturation....

Journal: :Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2008
Ludwig G Strauss Dirk Koczan Sven Klippel Leyun Pan Caixia Cheng Stefan Willis Uwe Haberkorn Antonia Dimitrakopoulou-Strauss

UNLABELLED 18F-FDG kinetics are primarily dependent on the expression of genes associated with glucose transporters and hexokinases but may be modulated by other genes. The dependency of 18F-FDG kinetics on angiogenesis-related gene expression was evaluated in this study. METHODS Patients with primary colorectal tumors (n = 25) were examined with PET and 18F-FDG within 2 days before surgery. ...

Journal: :European heart journal 2013
Andreas Link Janine Pöss Ranja Rbah Christine Barth Luisa Feth Simina Selejan Michael Böhm

AIMS Vascular integrity is disturbed in shock contributing to clinical appearance and serious outcomes. While angiopoietin (Ang)-1 protects from vascular inflammation and leakage, Ang-2 disrupts endothelial barrier function. The imbalance of Ang-1 and Ang-2, their association to haemodynamic deterioration, and their prognostic relevance are not known and, thus, were prospectively evaluated in p...

Journal: :American journal of physiology. Heart and circulatory physiology 2008
Qin-Hui Tuo Heng Zeng Amanda Stinnett Heidi Yu Judy L Aschner Daun-Fang Liao Jian-Xiong Chen

Angiopoietin-1 (Ang-1) and angiopoietin-2 (Ang-2) are the two ligands of the Tie-2 receptor, a receptor tyrosine kinase that is expressed on the endothelium. A balanced angiopoietin/Tie-2 system is critical for the maintenance of vascular integrity. We investigated the potential role of a disrupted angiopoietin/Tie-2 system on hyperglycemic exacerbation of myocardial infarction and impaired ang...

2017
Kaci A. Bohn Chris E. Adkins Mohamed I. Nounou Paul R. Lockman

For metastases in the central nervous system, angiogenesis enhances metastatic potential and promotes progression. Primary factors which drive vessel growth are vascular endothelial growth factor (VEGF) and angiopoietin-2. Preclinical models show inhibition of either factor reduces metastases spread and inhibits growth. This work sets out to answer two questions in a preclinical mouse model. Fi...

Journal: :Development 2005
Gavin Thurston Quan Wang Fabienne Baffert John Rudge Nicholas Papadopoulos Danielle Jean-Guillaume Stanley Wiegand George D Yancopoulos Donald M McDonald

Early in development, endothelial cells proliferate, coalesce, and sprout to form a primitive plexus of undifferentiated microvessels. Subsequently, this plexus remodels into a hierarchical network of different-sized vessels. Although the processes of proliferation and sprouting are well studied and are dependent on the angiogenic growth factor VEGF, the factors involved in subsequent vessel re...

200420052006200720082009201020112012201320142015201620172018201920202021202220230100200300

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید